Trial Information
A Phase I, Open-Label Study of D-0502 Single Agent and D-0502 in Combination with Palbociclib in Women With Advanced or Metastatic ER- Positive and HER2-Negative Breast Cancer
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
